- testing |
| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 Jan 2026 | 29 Dec 2025 |
| Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve the Un-audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Nine Months ending on December 31, 2025 Outcome Of Board Meeting Dated January 30, 2026 (As per BSE Announcement dated on: 30.01.2026) Attached (As Per BSE Announcement Dated On : 23.01.2026) | ||
| Board Meeting | 31 Oct 2025 | 24 Oct 2025 |
| Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 inter alia to consider and approve 1. Un-audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Half Year ended September 30 2025; 2. declaration of 2nd Interim Dividend if any on the Equity Shares of the Company for the Financial Year 2025-26; & 3. Consider issuance of bonus shares in accordance with the applicable provisions and subject to approval of Shareholders of the Company. Outcome of Board Meeting held on October 31, 2025 (As per BSE Announcement dated on: 31.10.2025) | ||
| Board Meeting | 31 Jul 2025 | 24 Jul 2025 |
| Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 inter alia to consider and approve Un-audited Financial Results for the Quarter ended June 30 2025 and declaration of Interim Dividend if any for FY 2025-26 Attached (As Per BSE Announcement Dated on: 31.07.2025) | ||
| Board Meeting | 25 Apr 2025 | 18 Apr 2025 |
| Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2025 inter alia to consider and approve the Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Financial Year ended March 31 2025 and to consider recommending Final Dividend if any on the Equity Shares of the Company for the Financial Year ended March 31 2025. Attached Recommendation of final dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the financial year ended March 31, 2025, subject to approval of the Members of the Company at ensuing Annual General Meeting (AGM). The record date for the purpose of payment of final dividend shall be June 06, 2025. The Final Dividend will be dispatched/ credited within 30 days of the approval by the Members. (As Per BSE Announcement Dated on 25.04.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
